These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 27517329)

  • 21. Virion stiffness regulates immature HIV-1 entry.
    Pang HB; Hevroni L; Kol N; Eckert DM; Tsvitov M; Kay MS; Rousso I
    Retrovirology; 2013 Jan; 10():4. PubMed ID: 23305456
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RNA and Nucleocapsid Are Dispensable for Mature HIV-1 Capsid Assembly.
    Mattei S; Flemming A; Anders-Össwein M; Kräusslich HG; Briggs JA; Müller B
    J Virol; 2015 Oct; 89(19):9739-47. PubMed ID: 26178992
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIV-1 protease with leucine zipper fused at N-terminus exhibits enhanced linker amino acid-dependent activity.
    Yu FH; Wang CT
    Retrovirology; 2018 Apr; 15(1):32. PubMed ID: 29655366
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of an HIV-1 Mutation in Spacer Peptide 1 That Stabilizes the Immature CA-SP1 Lattice.
    Fontana J; Keller PW; Urano E; Ablan SD; Steven AC; Freed EO
    J Virol; 2016 Jan; 90(2):972-8. PubMed ID: 26537676
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Maturation of human immunodeficiency virus particles assembled from the gag precursor protein requires in situ processing by gag-pol protease.
    Ross EK; Fuerst TR; Orenstein JM; O'Neill T; Martin MA; Venkatesan S
    AIDS Res Hum Retroviruses; 1991 May; 7(5):475-83. PubMed ID: 1873082
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proteolytic processing of the p2/nucleocapsid cleavage site is critical for human immunodeficiency virus type 1 RNA dimer maturation.
    Shehu-Xhilaga M; Kraeusslich HG; Pettit S; Swanstrom R; Lee JY; Marshall JA; Crowe SM; Mak J
    J Virol; 2001 Oct; 75(19):9156-64. PubMed ID: 11533179
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subcellular Localization of HIV-1
    Becker JT; Sherer NM
    J Virol; 2017 Mar; 91(6):. PubMed ID: 28053097
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of the C terminus Gag protein in human immunodeficiency virus type 1 virion assembly and maturation.
    Yu XF; Matsuda Z; Yu QC; Lee TH; Essex M
    J Gen Virol; 1995 Dec; 76 ( Pt 12)():3171-9. PubMed ID: 8847526
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-resolution structures of HIV-1 Gag cleavage mutants determine structural switch for virus maturation.
    Mattei S; Tan A; Glass B; Müller B; Kräusslich HG; Briggs JAG
    Proc Natl Acad Sci U S A; 2018 Oct; 115(40):E9401-E9410. PubMed ID: 30217893
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [What's going on post-budding?].
    Sakuragi J
    Uirusu; 2011 Jun; 61(1):91-8. PubMed ID: 21972560
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure-Activity Relationships of the Human Immunodeficiency Virus Type 1 Maturation Inhibitor PF-46396.
    Murgatroyd C; Pirrie L; Tran F; Smith TK; Westwood NJ; Adamson CS
    J Virol; 2016 Sep; 90(18):8181-97. PubMed ID: 27384665
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structure of the HIV immature lattice allows for essential lattice remodeling within budded virions.
    Guo S; Saha I; Saffarian S; Johnson ME
    Elife; 2023 Jul; 12():. PubMed ID: 37435945
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The structure and flexibility of conical HIV-1 capsids determined within intact virions.
    Mattei S; Glass B; Hagen WJ; Kräusslich HG; Briggs JA
    Science; 2016 Dec; 354(6318):1434-1437. PubMed ID: 27980210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Construction and characterization of a fluorescently labeled infectious human immunodeficiency virus type 1 derivative.
    Müller B; Daecke J; Fackler OT; Dittmar MT; Zentgraf H; Kräusslich HG
    J Virol; 2004 Oct; 78(19):10803-13. PubMed ID: 15367647
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proteolytic activity of human immunodeficiency virus Vpr- and Vpx-protease fusion proteins.
    Wu X; Liu H; Xiao H; Kappes JC
    Virology; 1996 May; 219(1):307-13. PubMed ID: 8623547
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of human immunodeficiency virus type 1 Pr160 gag-pol mutants with truncations downstream of the protease domain.
    Liao WH; Wang CT
    Virology; 2004 Nov; 329(1):180-8. PubMed ID: 15476885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. C-Terminal HIV-1 Transframe p6* Tetrapeptide Blocks Enhanced Gag Cleavage Incurred by Leucine Zipper Replacement of a Deleted p6* Domain.
    Yu FH; Huang KJ; Wang CT
    J Virol; 2017 May; 91(10):. PubMed ID: 28250114
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Three-Dimensional Structural Characterization of HIV-1 Tethered to Human Cells.
    Strauss JD; Hammonds JE; Yi H; Ding L; Spearman P; Wright ER
    J Virol; 2016 Feb; 90(3):1507-21. PubMed ID: 26582000
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Binding kinetics and substrate selectivity in HIV-1 protease-Gag interactions probed at atomic resolution by chemical exchange NMR.
    Deshmukh L; Tugarinov V; Louis JM; Clore GM
    Proc Natl Acad Sci U S A; 2017 Nov; 114(46):E9855-E9862. PubMed ID: 29087351
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human immunodeficiency virus type 1 protease inhibitors irreversibly block infectivity of purified virions from chronically infected cells.
    Lambert DM; Petteway SR; McDanal CE; Hart TK; Leary JJ; Dreyer GB; Meek TD; Bugelski PJ; Bolognesi DP; Metcalf BW
    Antimicrob Agents Chemother; 1992 May; 36(5):982-8. PubMed ID: 1510424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.